Skip to main content
OH

OffScrip Health

OffScrip Health produces educational podcast series in partnership with biopharmaceutical companies to improve patient awareness and outcomes. Their platform focuses on oncology and rare diseases, using audio to enhance patient engagement with unbranded campaigns.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Patients often lack sufficient understanding of complex medical conditions, especially in specialized areas like oncology and rare diseases, leading to poor adherence to treatment plans and suboptimal health outcomes. Traditional educational materials may be difficult to access, understand, or engage with, particularly for patients with limited health literacy or those facing challenging circumstances.

Solution

OffScrip Health partners with biopharmaceutical companies to create and distribute educational podcast series designed to improve patient awareness and understanding of specific diseases and treatments. These audio programs focus on oncology and rare diseases, providing easily accessible and engaging content that enhances patient knowledge and promotes better health outcomes. By leveraging the accessibility of audio, OffScrip Health aims to bridge the knowledge gap between patients and healthcare providers, empowering individuals to make informed decisions about their health. The podcasts are designed to be unbranded, focusing on education rather than promotion.

Target Audience

The primary audience includes patients diagnosed with cancer or rare diseases, their caregivers, and healthcare professionals seeking supplementary educational resources.

Features

  • Educational podcast series focused on oncology and rare diseases
  • Partnerships with biopharmaceutical companies to ensure medical accuracy
  • Unbranded content to maintain objectivity and build patient trust
  • Audio format for accessibility and ease of consumption
This profile is AI-generated and may contain inaccuracies.